Skip to main content

Breadcrumb

  1. Home

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

Submitted by Anonymous (not verified) on Tue, 01/27/2026 - 13:49
  • Read more about A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

E-Mindfulness Approaches for Living After Breast Cancer

Submitted by Anonymous (not verified) on Thu, 01/22/2026 - 14:57
  • Read more about E-Mindfulness Approaches for Living After Breast Cancer

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Submitted by Anonymous (not verified) on Thu, 01/22/2026 - 14:57
  • Read more about Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Submitted by Anonymous (not verified) on Thu, 01/22/2026 - 14:57
  • Read more about A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

Submitted by Anonymous (not verified) on Fri, 01/16/2026 - 19:46
  • Read more about FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid Leukemia

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

Submitted by Anonymous (not verified) on Fri, 01/16/2026 - 19:46
  • Read more about A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Submitted by Anonymous (not verified) on Fri, 01/16/2026 - 19:44
  • Read more about A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Safety Study of ViaskinĀ® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Submitted by Anonymous (not verified) on Tue, 01/06/2026 - 13:52
  • Read more about Safety Study of ViaskinĀ® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

Supporting Responsible Fatherhood Program (Fatherhood FIRE)

Submitted by Anonymous (not verified) on Tue, 01/06/2026 - 13:51
  • Read more about Supporting Responsible Fatherhood Program (Fatherhood FIRE)

A Study of CTD402 in T-ALL/LBL Patients

Submitted by Anonymous (not verified) on Wed, 12/31/2025 - 20:12
  • Read more about A Study of CTD402 in T-ALL/LBL Patients

Pagination

  • First page First
  • Previous page Previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next
  • Last page Last
Subscribe to